通过临床药物遗传学实施联盟 (CPIC) 在全球推进临床药物遗传学
Kelly E Caudle1, Michelle Whirl-Carrillo2, Mary V Relling1
1Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
临床药物遗传学实施联盟 (CPIC) 提供了全球基因/药物指南,加速了药物遗传学的采用. 现在,CPIC是实施医疗保健中药基因组测试的主要资源.
科学领域:
- 药物基因组学 药物基因组学
- 临床实施科学 临床实施科学
- 遗传学和医学
背景情况:
- 自2009年以来,临床药物遗传学实施联盟 (CPIC) 已经制定了基于证据的基因/药物指南.
- CPIC指南是将药物基因组测试结果转化为处方决定的全球标准.
研究的目的:
- 总结关于CPIC在加速药物基因组学采用的作用的数据.
- 评估CPIC的增长,影响和演变,作为临床实施的领先资源.
主要方法:
- 分析会员人口统计,指南特征,作者身份,参考资料,API使用情况和现实世界的实施情况.
- 使用了内部跟踪,Scopus,iCite,网站分析,PubMed评论 (2019-2024) 和会员调查 (2012,2024).
主要成果:
- CPIC有28个活跃的指导方针,1万多次引用,140万次浏览,国际版权和广泛采用.
- 85%的PubMed索引的药物基因组实施研究引用CPIC;128个机构和40个实验室使用CPIC内容.
- CPIC API的使用量超过8万个月查询,EHR的集成越来越多;调查表明,实际实施障碍正在转变.
结论:
- CPIC已成为制药基因组学实施的全球领导者,促进合作和标准化.
- CPIC的演变支持将药物基因组学可持续纳入各种医疗保健环境.
- 焦点正在从指导方针开发转向解决临床采用中的实际挑战.
更多相关视频
09:30Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
Published on: August 17, 2022
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
相关概念视频
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Biopharmaceutics and Pharmacokinetics: Overview
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacodynamics: Overview and Principles
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Single Nucleotide Polymorphisms-SNPs
